Yao Liu

Yao Liu

Auto-generated profile, based on publicly available information

Yao Liu

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
XLXi Luo
Xi Luo
DWDavid J. Wasilko
David J. Wasilko
YLYao Liu
Yao Liu
JSJiayi Sun
Jiayi Sun
XWXiaochun Wu
Xiaochun Wu
YMYuxin Mao
Yuxin Mao
The opportunistic intracellular pathogen Legionella pneumophila is the causative agent of Legionnaires’ disease. L. pneumophila delivers nearly 300 effector proteins into host cells for the establishment of a replication-permissive compartment known as the Legionella-containing vacuole (LCV). SidC and its paralog SdcA are two effectors that have been shown to anchor on the LCV via binding to phosphatidylinositol-4-phosphate [PI(4)P] to facilitate the recruitment of ER proteins to the LCV. We recently reported that the N-terminal SNL (SidC N-terminal E3 Ligase) domain of SidC is a ubiquitin E3 ligase, and its activity is required for the recruitment of ER proteins to the LCV. Here we report the crystal structure of SidC (1-871). The structure reveals that SidC contains four domains that are packed into an arch-like shape. The P4C domain (PI(4)P binding of SidC) comprises a four α-helix bundle and covers the ubiquitin ligase catalytic site of the SNL domain. Strikingly, a pocket with characteristic positive electrostatic potentials is formed at one end of this bundle. Liposome binding assays of the P4C domain further identified the determinants of phosphoinositide recognition and membrane interaction. Interestingly, we also found that binding with PI(4)P stimulates the E3 ligase activity, presumably due to a conformational switch induced by PI(4)P from a closed form to an open active form. Mutations of key residues involved in PI(4)P binding significantly reduced the association of SidC with the LCV and abolished its activity in the recruitment of ER proteins and ubiquitin signals, highlighting that PI(4)P-mediated targeting of SidC is critical to its function in the remodeling of the bacterial phagosome membrane. Finally, a GFP-fusion with the P4C domain was demonstrated to be specifically localized to PI(4)P-enriched compartments in mammalian cells. This domain shows the potential to be developed into a sensitive and accurate PI(4)P probe in living cells. Legionnaires’ disease is caused by the intracellular bacterial pathogen Legionella pneumophila. Successful infection by this bacterium requires a special secretion system that injects nearly 300 effector proteins into the cytoplasm of host cells. The effector SidC and its paralog SdcA anchor on the Legionella-containing vacuole (LCV) and are important for the recruitment of ER proteins to the LCV. Recent data demonstrated that SidC and SdcA are ubiquitin E3 ligases and that their activity is required for the enrichment of ER proteins and ubiquitin conjugates on the LCV. Here we present the crystal structure of SidC revealing the architecture of a novel PI(4)P-binding module. Our biochemical and cell biological studies highlight key determinants involved in PI(4)P-binding and membrane insertion. Characterization of this novel PI(4)P binding module opens a potential avenue for the development of an accurate in vivo PI(4)P probe. Our data also reveals a distinct regulatory mechanism of the ubiquitin E3 ligase activity of SidC, which is activated by the lipid molecule, PI(4)P. Furthermore, our results suggest that proper spatial localization of SidC to the cytoplasmic surface of the bacterial phagosome through the binding with PI(4)P is crucial to its function.

22 July 2019 in Nature
Verified
Journal Article
Closed access
PDF file
NGNinghai Gan
Ninghai Gan
XZXiangkai Zhen
Xiangkai Zhen
YLYao Liu
Yao Liu
XXXiaolong Xu
Xiaolong Xu
CHChunlin He
Chunlin He
ZLZhaoqing Luo
Zhaoqing Luo

23 May 2018 in Nature
Verified
Journal Article
Closed access
PDF file
AAAnil Akturk
Anil Akturk
DWDavid J. Wasilko
David J. Wasilko
XWXiaochun Wu
Xiaochun Wu
YLYao Liu
Yao Liu
YZYong Zhang
Yong Zhang
YMYuxin Mao
Yuxin Mao

12 May 2017 in Cell Research
Verified
Journal Article
Open access
PDF file
JQJiazhang Qiu
Jiazhang Qiu
KYKaiwen Yu
Kaiwen Yu
XFXiaowen Fei
Xiaowen Fei
YLYao Liu
Yao Liu
ENErnesto Nakayasu
Ernesto Nakayasu
ZLZhaoqing Luo
Zhaoqing Luo
Ubiquitination regulates many aspects of host immunity and thus is a common target for infectious agents. Recent studies have revealed that members of the SidE effector family of the bacterial pathogen Legionella pneumophila attack several small GTPases associated with the endoplasmic reticulum by a novel ubiquitination mechanism that does not require the E1 and E2 enzymes of the host ubiquitination machinery. In this case, ubiquitin is first activated by ADP-ribosylation at Arg42 by a mono-ADP-ribosyltransferase activity; the intermediate is then cleaved by a phosphodiesterase activity also residing within SdeA, concomitant with the attachment of ubiquitin to serine residues of substrate proteins via a phosphoribosyl linker. Here we demonstrate that the effect of SidEs is antagonized by SidJ, an effector encoded by a gene situated in the locus coding for three members of the SidE family (SdeC, SdeB and SdeA). SidJ reverses ubiquitination of SidEs-modified substrates by cleaving the phosphodiester bond that links phosphoribosylated ubiquitin to protein substrates. SidJ also displays classical deubiquitinase activity but does not require catalytic cysteine residues. Further, these deubiquitinase activities of SidJ are essential for its role in L. pneumophila infection. Finally, the activity of SidJ is required for efficiently reducing the abundance of ubiquitinated Rab33b in infected cells within a few hours after bacterial uptake. Our results establish SidJ as a ubiquitin-deconjugating enzyme that functions to impose temporal regulation on the activity of SidE effectors. SidJ may be important in future studies of signaling cascades mediated by this unique ubiquitination, one that also potentially regulates cellular processes in eukaryotic cells.

27 January 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YLYao Liu
Yao Liu
WZWenhan Zhu
Wenhan Zhu
YTYunhao Tan
Yunhao Tan
ENErnesto Nakayasu
Ernesto Nakayasu
CSChristopher J. Staiger
Christopher J. Staiger
ZLZhaoqing Luo
Zhaoqing Luo
Legionella pneumophila, the etiological agent of Legionnaires’ disease, replicates intracellularly in protozoan and human hosts. Successful colonization and replication of this pathogen in host cells requires the Dot/Icm type IVB secretion system, which translocates approximately 300 effector proteins into the host cell to modulate various cellular processes. In this study, we identified RavK as a Dot/Icm substrate that targets the host cytoskeleton and reduces actin filament abundance in mammalian cells upon ectopic expression. RavK harbors an H95EXXH99 motif associated with diverse metalloproteases, which is essential for the inhibition of yeast growth and for the induction of cell rounding in HEK293T cells. We demonstrate that the actin protein itself is the cellular target of RavK and that this effector cleaves actin at a site between residues Thr351 and Phe352. Importantly, RavK-mediated actin cleavage also occurs during L. pneumophila infection. Cleavage by RavK abolishes the ability of actin to form polymers. Furthermore, an F352A mutation renders actin resistant to RavK-mediated cleavage; expression of the mutant in mammalian cells suppresses the cell rounding phenotype caused by RavK, further establishing that actin is the physiological substrate of RavK. Thus, L. pneumophila exploits components of the host cytoskeleton by multiple effectors with distinct mechanisms, highlighting the importance of modulating cellular processes governed by the actin cytoskeleton in the intracellular life cycle of this pathogen. Actin is a core component of the actin cytoskeleton, which plays a crucial role in diverse cellular processes including cell migration, cytokinesis, endocytosis and vesicle trafficking. Therefore, it is not surprising that many pathogens target actin and/or proteins involved in the regulation of actin activity for their benefit. Legionella pneumophila, the etiological agent of Legionnaires’ disease, uses the Dot/Icm type IVB secretion system to transfer effectors into host cells to subvert host cellular processes for its intracellular replication. At least three Dot/Icm substrates, VipA, Ceg14 and LegK2 have been shown to modulate the host actin cytoskeleton. Here, by screening L. pneumophila Dot/Icm substrates that alter the actin cytoskeleton in mammalian cells, we have identified RavK as an additional effector that specifically disrupts actin organization. RavK harbors a canonical metalloprotease motif, which is essential for the RavK-mediated actin cytoskeleton disruption and cell- rounding phenotypes. We further demonstrate that RavK directly cleaves actin, generating a fragment with a diminished capacity to form actin filaments. Our results reveal a new mechanism for which an intravacuolar bacterium disrupts actin cytoskeleton through the cleavage of the actin molecule, rather than interfering with the endogenous actin regulation pathways or by posttranslational modification of the actin molecule, to benefit its intracellular life cycle.

1 June 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JZJianhua Zhao
Jianhua Zhao
KBKsenia Beyrakhova
Ksenia Beyrakhova
YLYao Liu
Yao Liu
CAClaudia P Alvarez
Claudia P Alvarez
SBStephanie A Bueler
Stephanie A Bueler
JRJohn L Rubinstein
John L Rubinstein
Intracellular pathogenic bacteria evade the immune response by replicating within host cells. Legionella pneumophila, the causative agent of Legionnaires’ Disease, makes use of numerous effector proteins to construct a niche supportive of its replication within phagocytic cells. The L. pneumophila effector SidK was identified in a screen for proteins that reduce the activity of the proton pumping vacuolar-type ATPases (V-ATPases) when expressed in the yeast Saccharomyces cerevisae. SidK is secreted by L. pneumophila in the early stages of infection and by binding to and inhibiting the V-ATPase, SidK reduces phagosomal acidification and promotes survival of the bacterium inside macrophages. We determined crystal structures of the N-terminal region of SidK at 2.3 Å resolution and used single particle electron cryomicroscopy (cryo-EM) to determine structures of V-ATPase:SidK complexes at ~6.8 Å resolution. SidK is a flexible and elongated protein composed of an α-helical region that interacts with subunit A of the V-ATPase and a second region of unknown function that is flexibly-tethered to the first. SidK binds V-ATPase strongly by interacting via two α-helical bundles at its N terminus with subunit A. In vitro activity assays show that SidK does not inhibit the V-ATPase completely, but reduces its activity by ~40%, consistent with the partial V-ATPase deficiency phenotype its expression causes in yeast. The cryo-EM analysis shows that SidK reduces the flexibility of the A-subunit that is in the ‘open’ conformation. Fluorescence experiments indicate that SidK binding decreases the affinity of V-ATPase for a fluorescent analogue of ATP. Together, these results reveal the structural basis for the fine-tuning of V-ATPase activity by SidK. V-ATPase-driven acidification of lysosomes in phagocytic cells activates enzymes important for killing of phagocytized pathogens. Successful pathogens can subvert host defenses by secreting effectors that target V-ATPases to inhibit lysosomal acidification or lysosomal fusion with other cell compartments. This study reveals the structure of the V-ATPase:SidK complex, an assembly formed from the interaction of host and pathogen proteins involved in the infection of phagocytic white blood cells by Legionella pneumophila. The structure and activity of the V-ATPase is altered upon SidK binding, providing insight into the infection strategy used by L. pneumophila and possibly other intravacuolar pathogens.